Patient management and docetaxel.
Potent new drugs such as docetaxel (Taxotere®) will alter our perspective on advanced breast cancer, allowing significant disease responses and symptom palliation in many patients. The toxicities associated with docetaxel are generally predictable and manageable and usually reversible. Docetaxel is suitable for use in the outpatient setting. This report describes early experience with the drug in a nurse-assisted day case chemotherapy clinic at the Velindre NHS Trust Hospital and offers practical guidance on the prevention and handling of side-effects.